- World Anti-Doping Code
- Prohibited List
- Therapeutic Use Exemptions
- Registered Testing Pool
- Testing and Results Management
- Sanctioning
- The IPOD
- The ISSF Anti-Doping Rules


The International Shooting Sport Federation (ISSF) is a signatory to the Code and follows the Code's mandate in all areas of its anti-doping program.


The ISSF follows the Prohibited List as a signatory to the Code. The List was first published in 1963 under the leadership of the International Olympic Committee. Since 2004, as mandated by the Code, the World Anti Doping Agency (WADA) is responsible for the preparation and publication of the List.

The Prohibited List is a cornerstone of the Code and a key component of world-wide harmonisation of anti-doping regulations and initiatives. It is an International Standard identifying Substances and Methods prohibited in-competition, out-of-competition, and in particular sports.

The Prohibited List is revised every year by WADA. The revised version comes into effect on January 1st of every calendar year. For a link to the current Prohibited List please see the Prohibited List section in our drop-down menu.

The ISSF reminds all national level and international-level shooters and shooter support personnel that the use beta blockers is prohibited and forbidden in shooting sport both In-Competition and Out-of-Competition.


Athletes may have illnesses or conditions that require them to take particular medications. If the medication an athlete is required to take to treat an illness or condition happens to fall under the Prohibited List, a Therapeutic Use Exemption (TUE) may give that athlete the authorization to take the needed medicine.


The ISSF has its own TUE Committee that considers all submitted TUE applications and that grants or denies TUEs to international-level athletes in shooting sport. All athletes intending to compete at the international-level must apply for and obtain a TUE from ISSF. The application must always be submitted at least 30 days before competing.


The criteria for granting a TUE are:

a. The Prohibited Substance or Prohibited Method in question is needed to treat an acute or chronic medical condition, such that the athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method were to be withheld.


b. The therapeutic use of the Prohibited Substance or Prohibited Method is highly unlikely to produce any additional enhancement of performance beyond what might be anticipated by a return to the Athlete’s normal state of health following the treatment of the acute or chronic medical condition.

c. There is no reasonable therapeutic alternative to the Use of the Prohibited Substance or Prohibited Method.

d. The necessity for the use of the Prohibited Substance or Prohibited Method is not a consequence, wholly or in part, of the prior use (without a TUE) of a substance or method which was prohibited at the time of such use.

Any national-level shooter holding a national-level TUE must inform ISSF of the TUE and request ISSF recognition of the TUE prior to competing in any international competition, failing which the national level TUE will be deemed to be non-valid at the international level. Should the ISSF TUEC decide to not recognize the national-TUE it will also be invalid for international competition.


Please see article 4.4 of the ISSF Anti-Doping Rules which deals with Therapeutic Use Exemptions.




The term Registered Testing Pool refers to the pool of top level shooters established by the ISSF and/or a relevant National Anti-Doping Organization who are subject to both In-Competition and Out-of-Competition testing as part of the ISSF or a National-Anti-Doping Organization's test distribution plan.

The ISSF’s Registered Testing Pool consists of the top five ten men and women in every category. The shooters who are in the ISSF Registered Testing Pool must provide their whereabouts on a quarterly basis, including all training camps and schedules. They must also provide a 60 minute time slot for which they can be available for testing every day of the year. Any failure to submit timely and accurate whereabouts information, or any failure to be present at the location and time indicated on the whereabouts information submitted, can result in sanctions.


The ISSF RTP will be reset and updated at each quarter and shooters are required to verify if they are included in the ISSF RTP for the current quarter.

Please be advised that all shooters who compete in ISSF events and who hold an ISSF ID are equally subject to both In-Competition and Out-of-Competition testing on a year-round basis.


In-Competition Testing in shooting sport is testing that is conducted in connection with any ISSF sanctioned event.

Out-of-Competition testing can occur at any time of the year (excluding the In-Competition Testing periods) and at any location, such as an athlete's home, place of training, or even while they are abroad for personal or training reasons. Out-of-Competition testing takes place with no advance notice to the athlete.


The ISSF works closely together with WADA and the National Anti-Doping Agencies in planning and conducting Out-Of-Competition Testing on shooters worldwide.


Adverse Analytical Finding (AAF)

Further to testing, the term Adverse Analytical Finding (AAF) refers to a report from a WADA accredited laboratory that indicates that the collected sample yielded the presence of a Prohibited Substance or its metabolites or markers (including elevated quantities of endogenous substances) or evidence of the use of a Prohibited Method.

The term Adverse Analytical Finding does not necessarily imply that an anti-doping rule violation (ADRV) has occurred as the athlete may have a TUE or may have elevated endogenous substances which are normal for his or her own system and do not necessarily reflect a positive doping infraction.

An AAF only becomes an asserted ADRV after a thorough investigation following due process, including a preliminary review and a formal enquiry, is completed.


Further to an ADRV being asserted a hearing shall take place and a decision shall be taken by the ISSF Executive Committee as to whether or not an ADRV has truly occurred and what the appropriate sanction should be under all the circumstances of the case.

Please see Article 5 of the ISSF Anti-Doping Rules which deals with Testing and Article 7 and 8 of the ISSF Anti-Doping Rules which deals with Results Management and Hearings.


The ISSF follows the Code and the ISSF Anti-Doping Rules when deciding on a sanction for shooters that have committed an anti-doping rule violation.


Please see Article 10 of the ISSF Anti-Doping Rules which deals with sanctions.

All sanctions imposed by the ISSF Executive Committee against shooters who have committed ADRVs will be posted on this website as they are decided.

ISSF Information Portal on Doping - IPOD

ISSF will also continue to disseminate educational materials via our member federations, through our

Information Portal On Doping (IPOD)

articles in the ISSF News publication and at some of our International Events by means of the Athlete Outreach Booth. We trust these tools will continue to educate all our Shooters and their support teams on the ISSF anti-doping program, the results management and sanctioning processes and the various negative implications of using performance enhancing drugs.


ISSF Anti-Doping Rules

In accordance with ISSF’s ongoing obligations under the Code, the ISSF Anti-Doping Rules and anti-doping program have been regularly modified and enhanced to remain in full compliance with the Code.